Background-Cardiac stem cells (CSCs) delivered to the infarcted heart generate a large number of small fetal-neonatal cardiomyocytes that fail to acquire the differentiated phenotype. However, the interaction of CSCs with postmitotic myocytes results in the formation of cells with adult characteristics. Methods and Results-On the basis of results of in vitro and in vivo assays, we report that the commitment of human CSCs (hCSCs) to the myocyte lineage and the generation of mature working cardiomyocytes are influenced by microRNA-499 (miR-499), which is barely detectable in hCSCs but is highly expressed in postmitotic human cardiomyocytes. miR-499 traverses gap junction channels and translocates to structurally coupled hCSCs favoring their differentiation into functionally competent cells. Expression of miR-499 in hCSCs represses the miR-499 target genes Sox6 and Rod1, enhancing cardiomyogenesis in vitro and after infarction in vivo. Although cardiac repair was detected in all cell-treated infarcted hearts, the aggregate volume of the regenerated myocyte mass and myocyte cell volume were greater in animals injected with hCSCs overexpressing miR-499. Treatment with hCSCs resulted in an improvement in ventricular function, consisting of a better preservation of developed pressure and positive and negative dP/dt after infarction. An additional positive effect on cardiac performance occurred with miR-499, pointing to enhanced myocyte differentiation/hypertrophy as the mechanism by which miR-499 potentiated the restoration of myocardial mass and function in the infarcted heart. Conclusions-The recognition that miR-499 promotes the differentiation of hCSCs into mechanically integrated cardiomyocytes has important clinical implications for the treatment of human heart failure. (Circulation. 2011;123:1287-1296.) 
M yocyte turnover in the adult heart is regulated by cardiac stem cells (CSCs) that generate new myocytes integrated structurally and functionally with the adjacent myocardium. 1 A similar phenomenon occurs with aging when cell renewal is enhanced by translocation, growth, and differentiation of CSCs, which lead to the formation of cardiomyocytes with characteristics indistinguishable from the neighboring cells. 2 This recovery of the integrity of the myocardium does not occur with acute and chronic infarcts after the injection of CSCs or their local activation by growth factors. 3, 4 A large number of myocytes are formed, but the new cells consist predominantly of clusters of small, proliferating, mononucleated myocytes. 5 Myocyte differentiation is partly prevented, suggesting that incomplete silencing of the gene program that governs the primitive state of CSCs interferes with the acquisition of the adult cell phenotype. Alternatively, CSCs may be arrested in the early committed phase by prolonged upregulation of the Notch1 receptor telomerase and Nkx2.5, which are the molecular determinants of amplifying myocytes. 5
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The occasional migration of CSCs from the border zone to the remote myocardium results in the formation of fully mature myocytes, mimicking cell turnover. 6 Although the mechanism regulating the growth of CSCs into small versus large myocytes is currently unknown, coupling of CSCs with postmitotic myocytes may be critical in determining their fate. MicroRNAs (miRs) are small RNAs that have the ability to traverse gap junctions 7 and by this means may migrate from cardiomyocytes to CSCs dictating their destiny. In the present study, we tested whether the commitment of CSCs to the myocyte lineage depends on their interaction with the surrounding myocytes with translocation of miRs, which promote CSC differentiation. Additionally, the effects of CSCs overexpressing miR were evaluated in vivo after myocardial infarction.
Methods
Detailed methods are available in the online-only Data Supplement.
Human CSCs and Rat CSCs
Human and rat myocardial samples were enzymatically dissociated, and c-kit-positive human CSCs (hCSCs) and rat CSCs (rCSCs) were obtained.
miR Microarray, Quantitative Reverse-Transcription Polymerase Chain Reaction, and Western Blotting
RNA was extracted and subjected to miR microarray or quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Protein lysates of hCSCs, human myocytes, rCSCs, and rat myocytes were used to measure Sox6 and Rod1.
miR-499 Transfer
Cardiomyocytes were cocultured with hCSCs, and luciferase reporter assays were used to document the functional competence of translocated miR-499.
Myocardial Infarction
Myocardial infarction was produced in rats, and hCSCs infected with an miR-499 -enhanced green fluorescence protein (EGFP) lentivirus were injected into the border zone. At the time of death, ventricular function was determined and the heart was fixed for histology.
Statistical Analysis
Continuous measurements are presented as meanϮSD. Comparisons between 2 groups were determined by the unpaired Student t test and Ͼ2 groups by the Newman-Keuls method. The latter test was performed only if the overall comparison based on 1-way ANOVA was statistically significant. In all cases, variances were assumed to be equal, and variables were assumed to be normally distributed. Values of PϽ0.05 were considered significant.
Results

Expression of miR-499 in the Heart
miRs are a class of small noncoding RNAs that negatively regulate gene expression by repressing protein translation or promoting mRNA degradation. 8 These short RNAs are not uniformly distributed in the organism but display a preferential localization that is organ and cell specific. Initially, the miR profile of the mouse myocardium was determined ( Table I in the online-only Data Supplement). The rat model was then used to isolate a larger number of myocytes and rCSCs for the evaluation of the differential expression of miRs in these 2 cell classes. By array analysis ( Table II in the online-only Data Supplement) , miR-1, miR-22, miR-30a, miR-30b, miR-30c, miR-133a, miR-133b, and miR-499 were abundant in myocytes ( Figure 1A) . Although miR-1, miR-133a, and miR-133b were well expressed in rCSCs, the level of miR-499 was much higher in myocytes than in rCSCs. A 400-fold difference was found by qRT-PCR ( Figure 1B Myogenic miRs are positioned within introns of myosin genes. 9 In a manner similar to miR-208, which is located within the intron of the ␣-myosin heavy chain gene, miR-499 is placed in the intron of the recently identified Myh7b gene. Myh7b is present in the brain, heart, skeletal muscle, and testis. It has only 70% homology with ␣and ␤-myosin heavy chain ( Figure IIA in the online-only Data Supplement), suggesting that Myh7b represents a distinct myosin gene with unknown function.
miR-499 and Myh7b are encoded in the same orientation in all species (Figure IIB in the online-only Data Supplement), indicating that they are transcribed concurrently. The level of Myh7b measured by qRT-PCR was 33-fold higher in rat cardiomyocytes than in rCSCs ( Figure 1C and Figure I in the online-only Data Supplement). A similar behavior was observed for miR-499, raising the possibility that translocation of miR-499 from cardiomyocytes to structurally coupled CSCs conditions their commitment to the myocyte lineage and cell differentiation.
miR-499 Target Genes
The findings in the rodent heart raised the question of whether a similar differential expression of miR-499 was present in human myocytes and hCSCs. miR-499 was essentially undetectable in hCSCs, whereas extremely high levels were found in cardiomyocytes ( Figure 2A and Figure II in the online-only Data Supplement). A Web-based targetprediction program was then used to identify putative target genes of miR-499 (Table III in the online-only Data Supplement). Among the genes that scored as strong predicted targets, on the basis of high complementarity and evolutionary conservation, we selected 2 genes: SRY (sex determining region Y)-box 6 (Sox6) and regulator of differentiation 1 (Rod1).
Sox6 is a transcription factor implicated in early myocyte commitment in embryos, 10 and Rod1 is an RNA binding protein that negatively modulates cell differentiation. 11 The 3Ј Sox6 and Rod1 transcripts were measured in human and rat myocytes and CSCs. Sox6 mRNA was 49-fold higher in human myocardium than in hCSCs, but Rod1 mRNA did not differ in these cell classes. Sox6 was 5-fold more abundant in rat myocytes than in rCSCs, and Rod1 was 8-fold higher in rCSCs than in cardiomyocytes ( Figure 2B and Figure I in the online-only Data Supplement). Importantly, Sox6 and Rod1 proteins were barely detectable in human and rat myocytes but were apparent in both hCSCs and rCSCs ( Figure 2C ).
To test whether miR-499 binds to Sox6 and Rod1 mRNA interfering with translation, a reporter assay was performed. We used 3T3 fibroblasts to minimize the influence of endogenous miR-499. The 3Ј UTRs of Sox6 and Rod1 were obtained by PCR and ligated downstream the luciferase coding sequence in 2 reporter plasmids. The interaction of miR-499 and the 3Ј UTRs of Sox6 and Rod1 was expected to downregulate luciferase expression. The 3T3 cells were transfected with a plasmid carrying miR-499; the expression of miR-499 was assessed by qRT-PCR and found to be 2300-fold higher than in cells transduced with blank plasmid ( Figure 2D and Figure I in the online-only Data Supplement). Cells overexpressing miR-499 were then cotransfected with reporter plasmids containing luciferase and the 3Ј UTR of Sox6 or Rod1. Cells transfected with plasmids carrying luciferase only were used as controls. Luciferase activity decreased in a dose-dependent manner with the quantity of plasmid used in the assay (Figure 2E ), suggesting that Sox6 and Rod1 were target genes of miR-499.
miR-499 Transfer and Gap Junctions
The in vitro experiments included the evaluation of several parameters: translocation of miR-499 from myocytes to neighboring hCSCs via gap junctions; transcript and protein levels of the miR-499 target genes, Sox6 and Rod1, in hCSCs; and expression of transcription factors specific to myocytes in hCSCs. These in vitro assays were complemented with in vivo studies to document the effects of hCSCs overexpressing miR-499 on myocardial regeneration after infarction and on phenotypic properties and mechanical behavior of new myocytes, as well as their impact on ventricular function.
To establish whether miR-499 had the ability to migrate from donor cells to recipient hCSCs, C2C12 myoblasts were first used as donor cells. To obtain high levels of expression, C2C12 myoblasts were transfected with a plasmid carrying miR-499 ( Figure 3A and Figure I in the online-only Data Supplement). C2C12 myoblasts were then cocultured with EGFP-tagged hCSCs, and the presence of miR-499 was documented by quantitative fluorescence in situ hybridization. Initially, miR-499 was restricted to C2C12 myoblasts ( Figure IV in the online-only Data Supplement), but 36 hours later, miR-499 was identified in EGFP-positive hCSCs. Connexin 43 was expressed at the interface between the 2 cell types, suggesting that translocation of miR-499 required the formation of functional gap junctions ( Figure 3B and 3C ). miR-499 was detected in 62% of hCSCs. Importantly, this value decreased to 18% with the gap junction inhibitor 18␣-glycyrrhetinic acid (␣-GA), documenting the critical role of gap junction channels in miR-499 transfer.
To exclude that the translocation of miR-499 was influenced by the nonphysiological level of miR-499 in transfected C2C12 cells, a similar protocol was used with neonatal rat cardiomyocytes. EGFP-labeled hCSCs were sorted 5 days after being cocultured with cardiomyocytes and compared with hCSCs seeded alone. Expression of miR-499, measured by qRT-PCR, was Ϸ200-fold higher in the cocultured cells ( Figure 3D ). This process was markedly attenuated by the gap junction inhibitor ␣-GA. Exposure of hCSCs to the medium obtained from myocyte cultures failed to increase miR-499 expression in hCSCs. The culture medium showed only in Ϸ60% of the cases minimal quantities of miR-499 by qRT-PCR, although small nucleolar RNA was found in all samples ( Figure IV in the online-only Data Supplement).
The localization of miR-499 in hCSCs was documented further by in situ hybridization and confocal microscopy. Thirtysix hours after coculture of these cells with cardiomyocytes, 35% of hCSCs were positive for miR-499, and this value was markedly decreased in the presence of ␣-GA ( Figure 3E and 3F). Additionally, the use of a scrambled probe failed to label hCSCs and cardiomyocytes. At the concentration used, ␣-GA had no impact on the viability of hCSCs and cardiomyocytes ( Figure 3G ). These findings minimize the effects of the negligible amount of miR-499 present in the medium and the occasional observation of myocyte death on the translocation of miR-499 from cardiomyocytes to hCSCs.
For real-time transfer, translocation of miR-499 through gap junctions was studied in living cells by fluorescent microscopy. The 5Ј side of mature miR-499 was labeled with the fluorescent dye Cy3 (Cy3-miR-499). Individual hCSCs were loaded with Cy3-miR-499 together with cascade blue, a blue fluorescent dye. Transfer of cascade blue between adjacent cells occurs through gap junctions 12 ; it was used as an indicator of functional cell-to-cell coupling. hCSCs were used because they express connexin 43 mRNA but lack the protein (Figure V in the online-only Data Supplement). However, after interaction with other cells, hCSCs form gap junctions. 4 Conversely, connexin 43 protein is widely expressed in mature cardiomyocytes, possibly confounding the protocol. Additionally, the unlabeled endogenous miR-499 in myocytes would compete with the labeled exogenous miR-499.
The translocation of cascade blue and Cy3-miR-499 to neighboring cells was followed by acquisition of serial images with an inverted microscope. The appearance of blue and red fluorescence, ie, cascade blue and Cy3-miR-499, in unlabeled hCSCs adjacent to the injected hCSCs was considered indicative of the formation of functional gap junctions, critical for miR-499 translocation ( Figure VI in the onlineonly Data Supplement). To test whether the translocated miR retained its function, hCSCs transfected with a plasmid carrying miR-499 were used as donor cells, and hCSCs transfected with a luciferase plasmid containing the 3Ј UTR of Sox6 were used as recipient cells. Donor and recipient cells were cocultured for 3 days. Luciferase activity decreased Ͼ40% in hCSCs cocultured with donor cells transduced with miR-499. This effect was abolished by ␣-GA ( Figure 3H ). Thus, miR-499 enters hCSCs via gap junction channels, preserving its function. This biological phenomenon has been called mircrine.
Function of miR-499 in hCSCs
To establish the role of miR-499 and its target genes in hCSC growth and differentiation, these cells were transfected with an expression vector or infected with a lentivirus carrying miR-499. The quantity of miR-499 in transduced hCSCs increased Ϸ4000-fold, but this change did not affect Sox6 and Rod1 transcripts (Figures I and VII in the online-only Data Supplement). However, protein levels of Sox6 and Rod1 were markedly decreased ( Figure 4A ). Importantly, upregulation of miR-499 decreased BrdU incorporation in hCSCs, and this attenuation in hCSC growth was coupled with enhanced expression of Nkx2.5 and GATA4 ( Figure 4B ; Figure VIII in the online-only Data Supplement).
To establish further whether the function of miR-499 in hCSC differentiation was mediated by Sox6 and Rod1, siRNA was used to block the synthesis of these 2 target genes. hCSCs transfected with siRNA-Sox6 and siRNA-Rod1 showed a 62% and 69% reduction in mRNA for Sox6 and Rod1, respectively ( Figure 4C and Figure I in the online-only Data Supplement). Additionally, the fraction of Nkx2.5-and GATA4-positive cells increased 2-fold. A 3-to 4-fold increase in the percentage of Nkx2.5-and GATA4-positive cells was found when hCSCs were transfected with both siRNA-Sox6 and siRNA-Rod1 ( Figure 4D) . Thus, miR-499 promotes hCSC differentiation, which is medi- 
miR-499 and Myocardial Regeneration
Our in vitro results suggested that miR-499 may have significant implications in myocardial regeneration, favoring the formation of functionally competent myocytes. To test this possibility, hCSCs infected with a lentiviral vector carrying miR-499 and EGFP (miR-499 -EGFP-hCSCs) were injected soon after infarction in the border zone of immunosuppressed rats. The high level of expression of miR-499 was confirmed by qRT-PCR ( Figure IX in the online-only Data Supplement). Infarcted rats injected with EGFP-positive hCSCs (EGFP-hCSCs) were used as controls. Animals were exposed continuously to BrdU and euthanized 10 to 14 days later.
In all hearts, infarct size involved 50% of left ventricular myocytes ( Figure X in the online-only Data Supplement). Myocardial regeneration was detected in the 2 cell-treated groups and consisted of clusters of closely packed human cardiomyocytes ( Figure 5A ). The fraction of human myocytes that incorporated BrdU was Ϸ95% in both cell-treated infarcted hearts, indicating that human cells were continuously added over the 10-to 14-day period after coronary occlusion and cell implantation ( Figure 5B) . Similarly, the level of myocyte formation, measured by the cell cycle protein Ki67, was comparable in these 2 groups of hearts ( Figure X in the online-only Data Supplement), documenting that myocyte regeneration was ongoing at the time of death ( Figure 5C ).
The human origin of these regenerated structures was confirmed by the detection of EGFP and human DNA sequences with an Alu probe ( Figure 5D ). The specificity of immunolabeling for EGFP, ␣-sarcomeric actin, BrdU, Ki67, and Alu was confirmed by spectral analysis ( Figure XI in the online-only Data Supplement). Connexin 43 and N-cadherin were present between regenerated human myocytes ( Figure  6A ). Myocytes derived from differentiation of miR-499 -EGFP-hCSCs appeared to be larger, and sarcomere striation was more evident (see Figure 5D ). The aggregate volume of the regenerated myocyte mass and myocyte cell volume were 2.1-fold (PϽ0.02) and 1.44-fold (PϽ0.005) greater, respectively, in animals injected with miR-499 -EGFP-hCSCs (Figure 6B) . Moreover, the frequency distribution of the volume of human myocytes formed by miR-499 -EGFP-hCSCs was shifted to the right to higher values ( Figure 6C ). This analysis included EGFP-labeled myocytes Ն600 m 3 in volume because myofibrils were not seen in smaller cells.
Treatment with EGFP-hCSCs or miR-499 -EGFP-hCSCs resulted in an improvement in left ventricular function, consisting of better preservation of left ventricular developed pressure and positive and negative dP/dt. An additional positive effect on cardiac performance was found in the presence of miR-499 -EGFP-hCSCs ( Figure 7A ). Collectively, these findings point to enhanced myocyte differentiation/hypertrophy as the mechanism by which miR-499 potentiated the restoration of myocardial mass and function after infarction. However, whether this biological role of miR-499 in vivo was completed at this early stage of ventricular remodeling remained unclear.
Because of this question, rats with infarcted hearts injected with EGFP-hCSCs and miR-499 -EGFP-hCSCs were euthanized 21 days later at the completion of the healing process, and myocytes were enzymatically dissociated from the infarcted region of the wall for the assessment of their volume and mechanical properties. Human myocytes derived from miR-499 -EGFP-hCSCs were 50% larger than those formed by EGFP-hCSCs ( Figure 7B and 7C) . Additionally, peak shortening of regenerated human myocytes was significantly higher than that of the hypertrophied rat myocytes collected from the surviving myocardium ( Figure 7D ). This observation is consistent with the enhanced contractile function of young myocytes and the depressed mechanical behavior of hypertrophied cells. 13 Thus, overexpression of miR-499 promotes the progression of amplifying myocytes to the functionally competent adult phenotype.
Discussion
The results of the present study indicate that the commitment of hCSCs to the myocyte lineage and the generation of functionally competent adult cardiomyocytes are influenced by miR-499, which is barely detectable in primitive cells but is highly expressed in postmitotic human cardiomyocytes. Consistent with our in vitro observations, miR-499 traverses gap junction channels and may translocate in vivo from cardiomyocytes to structurally coupled hCSCs favoring the activation of the differentiation program.
The control of stem cell growth is not intrinsic to stem cells but depends on communications with the microenvironment. Interstitial structures with the architectural organization of stem cell niches are present in the mammalian heart. 1, 2, 4, 14 hCSCs form clusters and interact with the adjacent supporting cells through adherens and gap junctions, which are located at the interface between undifferentiated cells and myocytes or fibroblasts. 4 Although the roles of these 2 types of junction remain to be defined, it is reasonable to assume that they allow stem cells to sense environmental stimuli. Attenuation in cell-to-cell communication may occur with age, as supported by data in animal models. 2 The mircrine mechanism may be partly impaired, interfering with the activation of CSCs and progeny formation in the old heart.
In several organs, gap junctions favor replication, migration, and maturation of progenitor cells. 15, 16 The lack of an appropriate connection between hCSCs and the surrounding myocytes may oppose hCSC differentiation. Experimentally, the injection of hCSCs results in cardiac repair with significant recovery of muscle mass, but the human myocytes resemble fetal-neonatal cells. 4 Additionally, foci of small differentiating myocytes have been found after acute myo-cardial infarction or chronic aortic stenosis in humans. 17, 18 Conversely, newly formed cardiomyocytes in the context of a preserved myocardium typically show an adult phenotype, being indistinguishable from the adjacent cells. 6 These obser- vations raise challenging questions about the control of cardiac homeostasis and tissue regeneration.
Scattered myocyte dropout by wear and tear, aging, or cardiotoxicity is readily recovered by activation of CSCs. 2, 19, 20 Although significant differences have been reported on the extent of myocyte turnover in humans, 19 -21 there is general agreement that this process preserves the integrity of the myocardium. Conversely, segmental losses of tissue after infarction exceed the growth reserve of the organ, precluding cardiac repair. 18 Human cardiac stem cells maintain the balance between cell death and regeneration in the young adult heart, but this compensatory mechanism is no longer effective later in life 21 or after severe myocardial injury. 18 The recognition that miR-499 enhances the hypertrophic response of hCSC-derived cardiomyocytes, promoting a more effective functional and structural recovery of the damaged heart, offers a novel strategy for the management of the human disease.
The factors that govern hCSC growth appear to be regulated by junctional coupling and the translocation of miR-499 from postmitotic myocytes. The inhibitory function of miR-499 on Sox6 and Rod1 in hCSC differentiation may be mediated by repression of stemness-related genes and/or upregulation of lineage-specific genes. miR-499 expression and Sox6 inhibition enhance the differentiation of a heterogeneous population of fetal cardiac human cells. 22 However, these cells were erroneously considered a class of cardiac progenitors; they express the myocyte-specific transcription factors Nkx2.5, GATA4, and MEF2C, together with a poorly organized myofibrillar compartment, typically present in fetal-neonatal cardiomyocytes. The demonstration that myogenic miRs, including miR-1 and miR-499, favor their evolution toward a more mature phenotype is consistent with the results of the present study in which the critical role of miR-499 was documented at the level of the controlling cell, ie, the hCSC. Similar findings have been reported in embryonic stem cells. 23 A group of miRs have been found to be highly represented in the intact mammalian heart, including humans. 9 These miRs are dynamically regulated in cardiac diseases, suggesting that inhibition of their target genes may be involved in the control of cardiac hypertrophy and fibrosis. However, the actual role of the muscle specific miR-1 in human heart failure is open to question, and the function of miR-21 in pathological ventricular remodeling has been challenged. 24 Importantly, miR-29 inhibits a cluster of genes regulating tissue fibrosis, whereas miR-195, miR-199a, and miR-320 are critical determinants of cell viability in myocardial ischemia. 9 Myosin-encoded miRs form a hierarchically organized network of small RNAs that control the expression of contractile genes. 8 Although miR-208a appears to occupy an upstream position in the pathway regulating the shift in myosin expression, miR-499 replaces its function in miR-208a-null animals. 25 Unexpectedly, deletion of miR-208b and miR-499 lacks an overt cardiac phenotype, suggesting that a significant degree of redundancy exists among myogenic miRs.
Our findings document that miR-499 inhibits the expression of Sox6 and Rod1 only at the protein level. The incomplete base paring between the nucleotides flanking the seed region of miR-499 and its binding sequences on Sox6 and Rod1 mRNA indicates that repression of translation rather than mRNA degradation was the major mechanism of miR-499 function. This is consistent with the relatively large quantity of Sox6 and Rod1 transcripts in cardiomyocytes. Moreover, overexpression of miR-499 in hCSCs did not affect the mRNA level of Sox6 and Rod1 but abrogated protein accumulation. The apparent discrepancy between Sox6 and Rod1 mRNA in cardiomyocytes may be due to the presence of 5 and 2 miR-499 binding sequences in the 3Ј UTR of human Sox6 and Rod1 mRNA, respectively. The stronger inhibitory effect of miR-499 on Sox6-luciferase reporter assay supports this contention.
The existence of circulating miRs has raised the possibility that the function of these small RNAs may not be limited to the intracellular control of gene expression. 26 -29 Initially believed to be a passive leakage from dead cells, miR release is an organized and controlled process of secretion involving cell-derived microvesicles. 28, 30 Microvesicles may allow communication with cells located in organs distant from the cell of origin of miRs. 31, 32 In contrast, the exchange of small RNAs through gap junctions may be part of the complex cross-talk between neighboring functionally connected cells. To exclude that the presence of miR-499 in hCSCs was mediated by a paracrine mechanism, the level of miR-499 in the growth medium was measured and found to be negligible. Moreover, the gap junction inhibitor ␣-GA dramatically decreased the number of hCSCs positive for miR-499, pointing to gap junction channels as the major mediator of miR-499 transfer from cardiomyocytes to hCSCs. The recent documentation that miRs can traverse gap junction channels, a phenomenon confirmed here, has raised the intriguing possibility of a novel modality of intercellular control of gene expression. 7
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